Skip to main content

Featured Publications

Any text in center title
Kim, T., et al. “Hepatic Mtorc2 Signaling Facilitates Acute Glucagon Receptor Enhancement Of Insulin-Stimulated Glucose Homeostasis In Mice.”. Diabetes, pp. 2123-2135.
UAB
Castillo, J. J., et al. “Islet Amyloid Polypeptide Aggregation Exerts Cytotoxic And Proinflammatory Effects On The Islet Vasculature In Mice.”. Diabetologia, pp. 1687-1700.
Washington
Jhaveri, C. D., et al. “Aflibercept Monotherapy Or Bevacizumab First For Diabetic Macular Edema.”. The New England Journal Of Medicine, pp. 692-703.
Joslin
Nguyen, H. P., et al. “Aifm2 Is Required For High-Intensity Aerobic Exercise In Promoting Glucose Utilization.”. Diabetes, pp. 2084-2093.
Stanford
Ang, L. T., et al. “Generating Human Artery And Vein Cells From Pluripotent Stem Cells Highlights The Arterial Tropism Of Nipah And Hendra Viruses.”. Cell, pp. 2523-2541.e30.
Stanford
Foulon, N., et al. “Multiplexed Quantification Of Insulin And C-Peptide By Lc-Ms/Ms Without The Use Of Antibodies.”. Journal Of Mass Spectrometry And Advances In The Clinical Lab, pp. 19-26.
Washington
Wu, H., et al. “Mapping The Single-Cell Transcriptomic Response Of Murine Diabetic Kidney Disease To Therapies.”. Cell Metabolism, pp. 1064-1078.e6.
WUSTL
Sidarala, V., et al. “Mitofusin 1 And 2 Regulation Of Mitochondrial Dna Content Is A Critical Determinant Of Glucose Homeostasis.”. Nature Communications, p. 2340.
Michigan
Gosis, B. S., et al. “Inhibition Of Nonalcoholic Fatty Liver Disease In Mice By Selective Inhibition Of Mtorc1.”. Science (New York, N.y.), p. eabf8271.
Penn
Postigo-Fernandez, J., et al. “Preclinical Evaluation Of A Precision Medicine Approach To Dna Vaccination In Type 1 Diabetes.”. Proceedings Of The National Academy Of Sciences Of The United States Of America, p. e2110987119.
Columbia
Tang, Y., et al. “Tigar Deficiency Enhances Skeletal Muscle Thermogenesis By Increasing Neuromuscular Junction Cholinergic Signaling.”. Elife.
Einstein
Xu, G., et al. “Exploratory Study Reveals Far Reaching Systemic And Cellular Effects Of Verapamil Treatment In Subjects With Type 1 Diabetes.”. Nature Communications, p. 1159.
UAB